Transgene SA (TNG):企業の財務・戦略的SWOT分析

◆英語タイトル:Transgene SA (TNG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81795FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Transgene SA (Transgene) a subsidiary of Institut Merieux SA operates as a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targeted immunotherapeutics utilizing a broad range of viral vectors. Transgene also concentrates on discovery of a novel approach to improve digestion of DNA impurities in the manufacturing of viral vectors. The company operates through collaborations with numerous reference clinical centers, university hospitals and medical centers. It has operations in France, the US and China. Transgene is headquartered in Illkirch-Graffenstaden, France.

Transgene SA Key Recent Developments

Mar 10,2021: Transgene: Significant milestones achieved on all drug candidates in 2020 and financial visibility until 2022
Mar 02,2021: Transgene to present its immuno-oncology expertise at upcoming scientific conferences
Jan 14,2021: Transgene appoints Gaelle Stadtler as director of human resources
Dec 03,2020: Transgene appoints Hedi Ben Brahim as chairman and chief executive officer
Nov 05,2020: Transgene reports business update and end Q3 2020 financial position

This comprehensive SWOT profile of Transgene SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Transgene SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Transgene SA – Key Information
Transgene SA – Overview
Transgene SA – Key Employees
Transgene SA – Key Employee Biographies
Transgene SA – Key Operational Heads
Transgene SA – Major Products and Services
Transgene SA – History
Transgene SA – Company Statement
Transgene SA – Locations And Subsidiaries
Transgene SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Transgene SA – Business Description
Transgene SA – Corporate Strategy
Transgene SA – SWOT Analysis
SWOT Analysis – Overview
Transgene SA – Strengths
Transgene SA – Weaknesses
Transgene SA – Opportunities
Transgene SA – Threats
Transgene SA – Key Competitors

Section 3 – Company Financial Performance Charts

Transgene SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Transgene SA, Key Information
Transgene SA, Key Ratios
Transgene SA, Share Data
Transgene SA, Major Products and Services
Transgene SA, History
Transgene SA, Key Employees
Transgene SA, Key Employee Biographies
Transgene SA, Key Operational Heads
Transgene SA, Other Locations
Transgene SA, Subsidiaries
Transgene SA, Key Competitors
Transgene SA, SWOT Analysis
Transgene SA, Ratios based on current share price
Transgene SA, Annual Ratios
Transgene SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Transgene SA (TNG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oberg Industries Inc:企業の戦略的SWOT分析
    Oberg Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Starpharma Holdings Ltd (SPL):製薬・医療:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Snap-on Inc (SNA):企業の財務・戦略的SWOT分析
    Snap-on Inc (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bayer Healthcare Pharmaceuticals:企業の戦略・SWOT・財務情報
    Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report Summary Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Fujifilm SonoSite Inc-医療機器分野:企業M&A・提携分析
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Geisinger Health System-製薬・医療分野:企業M&A・提携分析
    Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Avanos Medical Inc (HYH):企業の財務・戦略的SWOT分析
    Summary Avanos Medical Inc (Avanos Medical) is a medical technology company. The company provides medical devices and equipment. It offers clinically-superior products and solutions in digestive health, pain management, infection prevention, surgical solutions and IV therapy. Avanos Medical provides …
  • Cerus Corp (CERS)-医療機器分野:企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Heidelberger Druckmaschinen AG (HDD):企業の財務・戦略的SWOT分析
    Heidelberger Druckmaschinen AG (HDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FRONTEO, Inc. (2158):企業の財務・戦略的SWOT分析
    FRONTEO, Inc. (2158) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Neuwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeuWave Medical Inc (NeuWave Medical), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. The company’s product Certus 140 microwave ablation (coagulation) system is a minimally invasive soft tissue abl …
  • Midatech Pharma Plc (MTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Airbus SAS:企業のM&A・事業提携・投資動向
    Airbus SAS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Airbus SAS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Apoteket AB:企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Societe Anonyme Belge de Constructions Aeronautiques:企業の戦略・SWOT・財務分析
    Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report Summary Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • European Medical Contract Manufacturing BV:医療機器:M&Aディール及び事業提携情報
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a developer and manufacturer of sterile medicinal products. The company’s products include bone cements for hip and knee arthroplasty and vertebroplasty procedures; cement restrictors; human bon …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆